Dr. Fedra Fallahian, MD

Dr. Fallahian practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Fallahian's NPI, 1821583618, was assigned on June 25, 2018. Dr. Fallahian graduated from UMKC School of Medicine in 2018. Dr. Fallahian holds Texas license U3836.

Dr. Fallahian's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Fallahian's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fallahian practices. Vendor and product names are available with a free account.

Surgical oncology is Dr. Fallahian's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Fallahian is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Fallahian's licenses on file in 2 states: Texas and Missouri.

Across all payers, Dmand AI patient panel data puts Dr. Fallahian's median patient age at 67, with 99% women.

In 2024, Dr. Fallahian wrote 46 Medicare Part D claims for 26 patients. 100% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $43 in total drug cost. In 2018, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Fallahian for performance year 2024, reported as part of a group. Dr. Fallahian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 35 procedures of mastectomy by Dr. Fallahian, more than 89% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Fallahian, published from 2017 to 2023. 2018 was the busiest year, with 2. Dr. Fallahian has published most often in Ann Plast Surg. Dr. Fallahian's most frequent co-authors are Kashyap Tadisina, MD, Ali Ardestani, MD, MS and Shahed Nicolas Badiyan, MD.

CMS Open Payments shows 13 general payments to Dr. Fallahian from 8 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 45% of the total. Vericel Corporation paid the most, $905.

Dr. Fallahian graduated from UMKC School of Medicine in 2018.

Dr. Fallahian is in network with 3 carriers, including Blue Cross Blue Shield of Michigan, Aetna and CMS Medicare. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.